Sendai virus envelope-mediated fusion was used to transfer plasma membrane vesicles of ESb lymphoma cells (H-2d) to syngeneic or allogeneic recipient cells. After fusion, ESb-specific cell surface determinants were detectable on the recipient cells, as revealed by indirect immunofluorescence and cytofluorographic analysis. Fused cells were also tested as targets in 51Cr-release assays, using syngeneic DBA/2 anti-ESb- or anti-H-2d-specific T lymphocytes (CTL). Fused recipient cells became susceptible to lysis by both types of CTL, indicating that both tumour-specific and H-2d determinants were inserted on fusion. The experimental approach presented could be of help as an assay system for the molecular identification of tumour-specific transplantation antigens.